Cargando…
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855/ https://www.ncbi.nlm.nih.gov/pubmed/32642806 http://dx.doi.org/10.1007/s15010-020-01476-7 |
| _version_ | 1783555105464778752 |
|---|---|
| author | Cingolani, A. Tummolo, A. M. Montemurro, G. Gremese, E. Larosa, L. Cipriani, M. C. Pasciuto, G. Liperoti, R. Murri, R. Pirronti, T. Cauda, R. Fantoni, M. |
| author_facet | Cingolani, A. Tummolo, A. M. Montemurro, G. Gremese, E. Larosa, L. Cipriani, M. C. Pasciuto, G. Liperoti, R. Murri, R. Pirronti, T. Cauda, R. Fantoni, M. |
| author_sort | Cingolani, A. |
| collection | PubMed |
| description | A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks. |
| format | Online Article Text |
| id | pubmed-7340855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73408552020-07-08 Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab Cingolani, A. Tummolo, A. M. Montemurro, G. Gremese, E. Larosa, L. Cipriani, M. C. Pasciuto, G. Liperoti, R. Murri, R. Pirronti, T. Cauda, R. Fantoni, M. Infection Brief Report A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks. Springer Berlin Heidelberg 2020-07-08 2020 /pmc/articles/PMC7340855/ /pubmed/32642806 http://dx.doi.org/10.1007/s15010-020-01476-7 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Brief Report Cingolani, A. Tummolo, A. M. Montemurro, G. Gremese, E. Larosa, L. Cipriani, M. C. Pasciuto, G. Liperoti, R. Murri, R. Pirronti, T. Cauda, R. Fantoni, M. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title | Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title_full | Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title_fullStr | Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title_full_unstemmed | Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title_short | Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab |
| title_sort | baricitinib as rescue therapy in a patient with covid-19 with no complete response to sarilumab |
| topic | Brief Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855/ https://www.ncbi.nlm.nih.gov/pubmed/32642806 http://dx.doi.org/10.1007/s15010-020-01476-7 |
| work_keys_str_mv | AT cingolania baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT tummoloam baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT montemurrog baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT gremesee baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT larosal baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT ciprianimc baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT pasciutog baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT liperotir baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT murrir baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT pirrontit baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT caudar baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT fantonim baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab AT baricitinibasrescuetherapyinapatientwithcovid19withnocompleteresponsetosarilumab |